{"id":8600,"date":"2019-11-12T17:12:09","date_gmt":"2019-11-12T22:12:09","guid":{"rendered":"https:\/\/www.silverlaw.com\/blog\/?p=8600"},"modified":"2019-11-12T17:12:09","modified_gmt":"2019-11-12T22:12:09","slug":"lipocine-lpcn","status":"publish","type":"post","link":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/","title":{"rendered":"Silver Law Group Investigates Lipocine Inc. (LPCN)"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft wp-image-8434 size-medium\" src=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3-300x200.jpg\" alt=\"Silver Law Group, a nationally-recognized class action law firm representing investors, is investigating Lipocine (LPCN), a publicly-traded specialty pharmaceutical company, on behalf of shareholders of the company\u2019s stock.  The investigation concerns whether Lipocine gave misleading information to the public and violated federal securities laws.\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3.jpg 300w, https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3-180x120.jpg 180w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/>Silver Law Group, a nationally-recognized <a href=\"https:\/\/www.silverlaw.com\/class-actions.html\" target=\"_blank\">class action<\/a> law firm representing investors, is investigating Lipocine (LPCN), a publicly-traded specialty pharmaceutical company, on behalf of shareholders of the company\u2019s stock.<\/p>\n<p>The investigation concerns whether Lipocine gave misleading information to the public and violated federal securities laws. <a href=\"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/#more-8600\" class=\"more-link\">Continue reading \u203a<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Silver Law Group, a nationally-recognized class action law firm representing investors, is investigating Lipocine (LPCN), a publicly-traded specialty pharmaceutical company, on behalf of shareholders of the company\u2019s stock. The investigation concerns whether Lipocine gave misleading information to the public and violated federal securities laws. Continue reading \u203a<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[602,590],"tags":[],"class_list":["post-8600","post","type-post","status-publish","format-standard","hentry","category-class-action","category-misrepresentation-and-omission-of-material-facts"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Silver Law Group Investigates Lipocine Inc. (LPCN)<\/title>\n<meta name=\"description\" content=\"Silver Law Group, a nationally-recognized class action law firm representing investors, is investigating Lipocine (LPCN) on behalf of shareholders.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Silver Law Group Investigates Lipocine Inc. (LPCN)\" \/>\n<meta name=\"twitter:description\" content=\"Silver Law Group, a nationally-recognized class action law firm representing investors, is investigating Lipocine (LPCN) on behalf of shareholders.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Silver Law Group\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Silver Law Group Investigates Lipocine Inc. (LPCN)","description":"Silver Law Group, a nationally-recognized class action law firm representing investors, is investigating Lipocine (LPCN) on behalf of shareholders.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/","twitter_card":"summary_large_image","twitter_title":"Silver Law Group Investigates Lipocine Inc. (LPCN)","twitter_description":"Silver Law Group, a nationally-recognized class action law firm representing investors, is investigating Lipocine (LPCN) on behalf of shareholders.","twitter_image":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3.jpg","twitter_misc":{"Written by":"Silver Law Group","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/#article","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/"},"author":{"name":"Silver Law Group","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"headline":"Silver Law Group Investigates Lipocine Inc. (LPCN)","datePublished":"2019-11-12T22:12:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/"},"wordCount":373,"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3-300x200.jpg","articleSection":["Class Action","Misrepresentation and Omission of Material Facts"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/","url":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/","name":"Silver Law Group Investigates Lipocine Inc. (LPCN)","isPartOf":{"@id":"https:\/\/www.silverlaw.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/#primaryimage"},"image":{"@id":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/#primaryimage"},"thumbnailUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3-300x200.jpg","datePublished":"2019-11-12T22:12:09+00:00","author":{"@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752"},"description":"Silver Law Group, a nationally-recognized class action law firm representing investors, is investigating Lipocine (LPCN) on behalf of shareholders.","breadcrumb":{"@id":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/#primaryimage","url":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3.jpg","contentUrl":"https:\/\/www.silverlaw.com\/blog\/wp-content\/uploads\/2019\/07\/Pills3.jpg","width":300,"height":200},{"@type":"BreadcrumbList","@id":"https:\/\/www.silverlaw.com\/blog\/lipocine-lpcn\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.silverlaw.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Silver Law Group Investigates Lipocine Inc. (LPCN)"}]},{"@type":"WebSite","@id":"https:\/\/www.silverlaw.com\/blog\/#website","url":"https:\/\/www.silverlaw.com\/blog\/","name":"Securities Arbitration Lawyers Blog","description":"Published by Securities Arbitration Lawyers \u2014 Silver Law Group","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.silverlaw.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.silverlaw.com\/blog\/#\/schema\/person\/de64d999508b1ad10d608a99f0d2e752","name":"Silver Law Group","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9eb0a691642ae95c68ee1c45b5f50f35bae76a41f3d9f861c7bfd40c87661746?s=96&d=mm&r=g","caption":"Silver Law Group"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/8600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/comments?post=8600"}],"version-history":[{"count":2,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/8600\/revisions"}],"predecessor-version":[{"id":8602,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/posts\/8600\/revisions\/8602"}],"wp:attachment":[{"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/media?parent=8600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/categories?post=8600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.silverlaw.com\/blog\/wp-json\/wp\/v2\/tags?post=8600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}